Skip to main navigation Skip to search Skip to main content

Dalteparin Sodium Injection (Fragmin, Multicenter, Open Label Single-Arm, Long Term (52 weeks) Study for Understanding Safety and Efficacy in Subjects with Malignancies and Symptomatic Venous Thromboembolism

Project: Research

Project Details

StatusFinished
Effective start/end date03/27/09 → 12/20/14

Funding

  • Eisai Medical Research Inc and its Affiliates: $24,962.00